However, further identification of the characteristic features of MDSC subsets in different types of human cancers dictated further investigations to redefine MDSCs according to a combination of a new set of markers, such as high levels of CD66b and low levels of CD62L and CD16 [20, 37, 38]. The gene discussed is CEACAM8; the disease is cancer.